TP53 and neoplasm: Moreover, we observed that mutations in TP53 were truncal in more than half of the patients (Fig. 2C), indicating that despite the tendency of pathogenic TP53 mutations to emerge later in the tumor’s evolution (21), a significant proportion occurred prior to tumor clonal dissemination from MRCA.